{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T20:29:32Z","timestamp":1794083372563,"version":"4.8.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.neuropharm.2020.108221","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T21:04:27Z","timestamp":1594242267000},"page":"108221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Fluoxetine rescues rotarod motor deficits in Mecp2 heterozygous mouse model of Rett syndrome via brain serotonin"],"prefix":"10.1016","volume":"176","author":[{"given":"Claudia","family":"Villani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Sacchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjana","family":"Carli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto W.","family":"Invernizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2020.108221_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2020.108221_bib2","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.1157871","article-title":"Sporadic autonomic dysregulation and death associated with excessive serotonin autoinhibition","volume":"321","author":"Audero","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.108221_bib3","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1038\/npp.2013.127","article-title":"Effect of serotonin on paired associative stimulation-induced plasticity in the human motor cortex","volume":"38","author":"Batsikadze","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108221_bib4","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/hmg\/ddr602","article-title":"Pharmacological interference with the glucocorticoid system influences symptoms and lifespan in a mouse model of Rett syndrome","volume":"21","author":"Braun","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2020.108221_bib5","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/ng.2714","article-title":"A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome","volume":"45","author":"Buchovecky","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2020.108221_bib6","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0031-9384(90)90089-M","article-title":"Behavioral and biochemical changes monitored in two inbred strains of mice during exploration of an unfamiliar environment","volume":"47","author":"Cabib","year":"1990","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2020.108221_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/0471142301.ns0812s15","article-title":"Motor coordination and balance in rodents","author":"Carter","year":"2001","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108221_bib8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1124\/mol.106.022301","article-title":"Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain","volume":"70","author":"Cassel","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108221_bib9","doi-asserted-by":"crossref","first-page":"8165","DOI":"10.1523\/JNEUROSCI.1816-05.2005","article-title":"Genotype-dependent activity of tryptophan hydroxylase-2 determines the response to citalopram in a mouse model of depression","volume":"25","author":"Cervo","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108221_bib10","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","article-title":"The story of Rett syndrome: from clinic to neurobiology","volume":"56","author":"Chahrour","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108221_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.neuron.2005.12.027","article-title":"The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression","volume":"49","author":"Chang","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108221_bib12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nature09582","article-title":"Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes","volume":"468","author":"Chao","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2020.108221_bib13","first-page":"219","article-title":"Presynaptic and postsynaptic modifications of the serotonin system by long-term administration of antidepressant treatments. An in vivo electrophysiologic study in the rat","volume":"5","author":"Chaput","year":"1991","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108221_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0130183","article-title":"MeCP2 affects skeletal muscle growth and morphology through non cell-autonomous mechanisms","volume":"10","author":"Conti","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.neuropharm.2020.108221_bib15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.resp.2013.02.015","article-title":"Serotonergic mechanisms are necessary for central respiratory chemoresponsiveness in situ","volume":"186","author":"Corcoran","year":"2013","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2020.108221_bib16","series-title":"Goodness-of-Fit Techniques","first-page":"367","article-title":"Tests for normal distribution","author":"D'Agostino","year":"1986"},{"key":"10.1016\/j.neuropharm.2020.108221_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/326184","article-title":"Deficient purposeful use of forepaws in female mice modelling Rett syndrome","volume":"2015","author":"De Filippis","year":"2015","journal-title":"Neural Plast."},{"key":"10.1016\/j.neuropharm.2020.108221_bib18","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108221_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.pbb.2016.01.011","article-title":"Sex and age differences in the antidepressant-like effect of fluoxetine in the forced swim test","volume":"152","author":"Fern\u00e1ndez-Guasti","year":"2017","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108221_bib20","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1152\/physrev.1983.63.2.484","article-title":"Role of precursor availability in control of monoamine biosynthesis in brain","volume":"63","author":"Fernstrom","year":"1983","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2020.108221_bib21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/mds.870050303","article-title":"Rett syndrome and associated movement disorders","volume":"5","author":"FitzGerald","year":"1990","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.neuropharm.2020.108221_bib22","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"1997"},{"key":"10.1016\/j.neuropharm.2020.108221_bib23","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/jnc.14114","article-title":"Adaptive dynamics of the 5-HT systems following chronic administration of selective serotonin reuptake inhibitors: a meta-analysis","volume":"142","author":"Fritze","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2020.108221_bib24","doi-asserted-by":"crossref","first-page":"13612","DOI":"10.1523\/JNEUROSCI.1854-13.2013","article-title":"Systemic delivery of MeCP2 rescues behavioral and cellular deficits in female mouse models of Rett syndrome","volume":"33","author":"Garg","year":"2013","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108221_bib25","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.neuroimage.2005.05.009","article-title":"Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects","volume":"27","author":"Gerdelat-Mas","year":"2005","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2020.108221_bib26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.pediatrneurol.2011.12.003","article-title":"Use of buspirone and fluoxetine for breathing problems in Rett syndrome","volume":"46","author":"Gokben","year":"2012","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108221_bib27","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/0028-3908(85)90153-4","article-title":"The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). A model of presynaptic 5-HT1 function","volume":"24","author":"Goodwin","year":"1985","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108221_bib28","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1126\/science.1138389","article-title":"Reversal of neurological defects in a mouse model of Rett syndrome","volume":"315","author":"Guy","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.108221_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejphar.2008.07.031","article-title":"Strain differences in paroxetine-induced reduction of immobility time in the forced swimming test in mice: role of serotonin","volume":"594","author":"Guzzetti","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108221_bib30","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ana.410140412","article-title":"A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases","volume":"14","author":"Hagberg","year":"1983","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108221_bib31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0893-133X(01)00395-5","article-title":"Differential regulation of 5-HT1A receptor-G protein interactions in brain following chronic antidepressant administration","volume":"26","author":"Hensler","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108221_bib32","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/sj.bjp.0706108","article-title":"Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors","volume":"144","author":"Hirano","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108221_bib33","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1124\/jpet.109.158717","article-title":"Sex-specific effects of chronic fluoxetine treatment on neuroplasticity and pharmacokinetics in mice","volume":"332","author":"Hodes","year":"2010","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108221_bib34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neulet.2005.05.056","article-title":"Defect in normal developmental increase of the brain biogenic amine concentrations in the mecp2-null mouse","volume":"386","author":"Ide","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2020.108221_bib35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0091-3057(95)02159-0","article-title":"Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex","volume":"54","author":"Invernizzi","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108221_bib36","series-title":"Microdialysis Techniques in Neuroscience, Neuromethods","first-page":"175","article-title":"Monitoring extracellular monoamines with in vivo microdialysis in awake rats: a practical approach","author":"Invernizzi","year":"2013"},{"key":"10.1016\/j.neuropharm.2020.108221_bib37","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.neuroscience.2009.11.036","article-title":"Postnatal changes in serotonergic innervation to the hippocampus of methyl-CpG-binding protein 2-null mice","volume":"165","author":"Isoda","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108221_bib38","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.neuron.2015.10.029","article-title":"Loss of MeCP2 in parvalbumin-and somatostatin-expressing neurons in mice leads to distinct Rett syndrome-like phenotypes","volume":"88","author":"Ito-Ishida","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108221_bib39","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1242\/dmm.011007","article-title":"Preclinical research in Rett syndrome: setting the foundation for translational success","volume":"5","author":"Katz","year":"2012","journal-title":"Model Mech"},{"key":"10.1016\/j.neuropharm.2020.108221_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2020.108221_bib41","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jneumeth.2011.10.001","article-title":"Noninvasive in vivo assessment of muscle impairment in the mdx mouse model \u2013 a comparison of two common wire hanging methods with two different results","volume":"203","author":"Klein","year":"2012","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.neuropharm.2020.108221_bib42","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1172\/JCI80323","article-title":"PTP1B inhibition suggests a therapeutic strategy for Rett syndrome","volume":"125","author":"Krishnan","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2020.108221_bib43","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1172\/JCI78167","article-title":"MECP2 disorders: from the clinic to mice and back","volume":"125","author":"Lombardi","year":"2015","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuropharm.2020.108221_bib44","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.neuroimage.2004.12.023","article-title":"Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer","volume":"27","author":"Loubinoux","year":"2005","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2020.108221_bib45","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1150516","article-title":"The antidepressant fluoxetine restores plasticity in the adult visual cortex","volume":"320","author":"Maya Vetencourt","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.108221_bib46","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1309426111","article-title":"beta2-Adrenergic receptor agonist ameliorates phenotypes and corrects microRNA-mediated IGF1 deficits in a mouse model of Rett syndrome","volume":"111","author":"Mellios","year":"2014","journal-title":"Proc Natl Acad Sci U A"},{"key":"10.1016\/j.neuropharm.2020.108221_bib47","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.14199","article-title":"Manipulations of MeCP2 in glutamatergic neurons highlight their contributions to Rett and other neurological disorders","volume":"5","author":"Meng","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.neuropharm.2020.108221_bib48","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1038\/sj.npp.1301497","article-title":"Genetic regulation of behavioral and neuronal responses to fluoxetine","volume":"33","author":"Miller","year":"2008","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.108221_bib49","doi-asserted-by":"crossref","first-page":"15742","DOI":"10.1523\/JNEUROSCI.2989-11.2011","article-title":"Chronic 5-HT transporter blockade reduces DA signaling to elicit basal ganglia dysfunction","volume":"31","author":"Morelli","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108221_bib50","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/npp.2012.116","article-title":"The impact of MeCP2 loss- or gain-of-function on synaptic plasticity","volume":"38","author":"Na","year":"2013","journal-title":"Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.108221_bib51","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.nbd.2007.02.003","article-title":"Postnatal dietary choline supplementation alters behavior in a mouse model of Rett syndrome","volume":"26","author":"Nag","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2020.108221_bib52","article-title":"Battery of behavioral tests assessing general locomotion, muscular strength, and coordination in mice","volume":"55491","author":"Osmon","year":"2018","journal-title":"JoVE"},{"key":"10.1016\/j.neuropharm.2020.108221_bib53","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-2202-12-47","article-title":"Biogenic amines and their metabolites are differentially affected in the Mecp2-deficient mouse brain","volume":"12","author":"Panayotis","year":"2011","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108221_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-24167-8","article-title":"Loss of MeCP2 in adult 5-HT neurons induces 5-HT1A autoreceptors, with opposite sex-dependent anxiety and depression phenotypes","volume":"8","author":"Philippe","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2020.108221_bib55","doi-asserted-by":"crossref","DOI":"10.1097\/00004714-199910001-00002","article-title":"Preclinical pharmacology of citalopram","volume":"19","author":"Popik","year":"1999","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.108221_bib56","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0387-7604(85)80044-9","article-title":"Neurochemical aspects of the Rett syndrome","volume":"7","author":"Riederer","year":"1985","journal-title":"Brain Dev."},{"key":"10.1016\/j.neuropharm.2020.108221_bib57","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1093\/brain\/aws096","article-title":"Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome","volume":"135","author":"Robinson","year":"2012","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108221_bib58","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0006-8993(88)91560-0","article-title":"Normalization of extracellular dopamine in striatum following recovery from a partial unilateral 6-OHDA lesion of the substantia nigra: a microdialysis study in freely moving rats","volume":"450","author":"Robinson","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108221_bib59","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0091-3057(98)00239-1","article-title":"Different levels of Fos immunoreactivity after repeated handling and injection stress in two inbred strains of mice","volume":"63","author":"Ryabinin","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108221_bib60","doi-asserted-by":"crossref","first-page":"21966","DOI":"10.1073\/pnas.0912257106","article-title":"Loss of MeCP2 in aminergic neurons causes cell-autonomous defects in neurotransmitter synthesis and specific behavioral abnormalities","volume":"106","author":"Samaco","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2020.108221_bib61","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/hmg\/dds406","article-title":"Female Mecp2(+\/-) mice display robust behavioral deficits on two different genetic backgrounds providing a framework for pre-clinical studies","volume":"22","author":"Samaco","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2020.108221_bib62","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.1083328","article-title":"Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants","volume":"301","author":"Santarelli","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.108221_bib63","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.neuroscience.2010.07.010","article-title":"Monoamine deficits in the brain of methyl-CpG binding protein 2 null mice suggest the involvement of the cerebral cortex in early stages of Rett syndrome","volume":"170","author":"Santos","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108221_bib64","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1601-183X.2006.00228.x","article-title":"A hitchhiker's guide to behavioral analysis in laboratory rodents","volume":"5","author":"Sousa","year":"2006","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.neuropharm.2020.108221_bib65","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.nbd.2014.12.005","article-title":"Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice","volume":"74","author":"Stagni","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2020.108221_bib66","doi-asserted-by":"crossref","first-page":"14288","DOI":"10.1038\/srep14288","article-title":"Reducing the stress of drug administration: implications for the 3Rs","volume":"5","author":"Stuart","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2020.108221_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.braindev.2018.03.010","article-title":"The course of awake breathing disturbances across the lifespan in Rett syndrome","author":"Tarquinio","year":"2018","journal-title":"Brain Dev."},{"key":"10.1016\/j.neuropharm.2020.108221_bib68","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1113\/expphysiol.2012.069872","article-title":"Increasing brain serotonin corrects CO2 chemosensitivity in methyl-CpG-binding protein 2 (Mecp2)-deficient mice","volume":"98","author":"Toward","year":"2013","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.neuropharm.2020.108221_bib69","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.14198","article-title":"Restoration of Mecp2 expression in GABAergic neurons is sufficient to rescue multiple disease features in a mouse model of Rett syndrome","volume":"5","author":"Ure","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.neuropharm.2020.108221_bib70","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.22409","article-title":"Lovastatin fails to improve motor performance and survival in methyl-CpG-binding protein2-null mice","volume":"5","author":"Villani","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.neuropharm.2020.108221_bib71","first-page":"27","article-title":"Motor coordination deficits and reduced levels of MeCP2 protein in motor brain regions of Mecp2 heterozygous mouse model of Rett syndrome are rescued by fluoxetine","author":"Villani","year":"2018","journal-title":"Rett Syndrome Research, Toward The Future. Rome, Italy, September"},{"key":"10.1016\/j.neuropharm.2020.108221_bib72","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fncir.2017.00072","article-title":"Monoaminergic modulation of motor cortex function","volume":"11","author":"Vitrac","year":"2017","journal-title":"Front. Neural Circ."},{"key":"10.1016\/j.neuropharm.2020.108221_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2017.00061","article-title":"Analysis of the serotonergic system in a mouse model of Rett syndrome reveals unusual upregulation of serotonin receptor 5b","volume":"10","author":"Vogelgesang","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108221_bib74","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ana.410250109","article-title":"Cerebrospinal fluid biogenic amines and biopterin in Rett syndrome","volume":"25","author":"Zoghbi","year":"1989","journal-title":"Ann. Neurol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820302896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820302896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:04:34Z","timestamp":1758438274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820302896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":74,"alternative-id":["S0028390820302896"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108221","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.12.147876","asserted-by":"object"}]},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluoxetine rescues rotarod motor deficits in Mecp2 heterozygous mouse model of Rett syndrome via brain serotonin","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108221","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108221"}}